Clinical trials
Active, not recruiting Non-Muscle Invasive Bladder Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 6 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 29 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ImmunityBio, Inc. | 3 |
| AstraZeneca | 2 |
| CG Oncology, Inc. | 2 |
| Janssen Research & Development, LLC | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| UroGen Pharma Ltd. | 2 |
| Aura Biosciences | 1 |
| ECOG-ACRIN Cancer Research Group | 1 |
| Fudan University | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-Muscle Invasive Bladder Neoplasms | 29 |
| Urinary Bladder Neoplasms | 16 |
| Carcinoma, Transitional Cell | 7 |
| Neoplasms | 3 |
| Recurrence | 2 |
| Urinary Bladder Diseases | 2 |
| Urogenital Neoplasms | 2 |
| Urologic Neoplasms | 2 |
| Carcinoma | 1 |
| Carcinoma in Situ | 1 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.